Literature DB >> 708574

Measurement of oestradiol receptors by five institutions on common tissue samples.

R J King, D M Barnes, R A Hawkins, R E Leake, P V Maynard, M M Roberts.   

Abstract

The soluble oestrogen-receptor content of common breast tumours has been measured by 5 different laboratories, each using their own assay procedure. Good agreement was achieved on whether a sample was positive or negative for oestrogen receptor. Qualitative differences between laboratories could be explained by differences in thiol-reagent content of assay medium and by the method of homogenization. Recommendations are made on some of the factors involved in the routine assay of receptors in breast tumours.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708574      PMCID: PMC2009740          DOI: 10.1038/bjc.1978.224

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  2 in total

1.  Reproducibility of measurements of oestrogen-receptor concentration in breast cancer.

Authors:  R A Hawkins; A Hill; B Freedman; S M Gore; M M Roberts; A P Forrest
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

2.  Oestrogen receptors and the response to endocrine therapy in advanced breast cancer.

Authors:  M M Roberts; R D Rubens; R J King; R A Hawkins; R R Millis; J L Hayward; A P Forrest
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

  2 in total
  7 in total

1.  Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.

Authors:  A Ahmad; A Hanby; E Dublin; R Poulsom; P Smith; D Barnes; R Rubens; P Anglard; I Hart
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

Review 2.  Quality control of estrogen receptor assays in The Netherlands.

Authors:  T Koenders; T J Benraad
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

3.  Oestrogen receptor activity in breast cancer detected at a prevalence screening examination.

Authors:  M M Roberts; R A Hawkins; F E Alexander; T J Anderson; R J Steele
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

4.  Oestrogen receptor concentration in primary breast cancer and axillary node metastases.

Authors:  R A Hawkins; R Black; R J Steele; J M Dixon; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

5.  Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.

Authors: 
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

6.  Oestrogen receptors and the response to endocrine therapy in advanced breast cancer.

Authors:  M M Roberts; R D Rubens; R J King; R A Hawkins; R R Millis; J L Hayward; A P Forrest
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

7.  The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.

Authors:  J M Howat; D M Barnes; M Harris; R Swindell
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.